Coronary and carotid atherosclerosis: similarities and differences.
暂无分享,去创建一个
Per Wester | Pranvera Ibrahimi | P. Ibrahimi | F. Jashari | R. Nicoll | Gani Bajraktari | P. Wester | M. Henein | Fisnik Jashari | Michael Y. Henein | Rachel Nicoll | Gani Bajraktari
[1] M. Davies,et al. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. , 1996, Circulation.
[2] R. Nicoll,et al. Arterial calcification: friend or foe? , 2013, International journal of cardiology.
[3] L. Symon,et al. Cerebral arterial pressure changes and development of leptomeningeal collateral circulation , 1963, Neurology.
[4] M. Levi,et al. Influenza vaccines for preventing coronary heart disease. , 2008, The Cochrane database of systematic reviews.
[5] D. O'leary,et al. Asymptomatic internal carotid artery stenosis defined by ultrasound and the risk of subsequent stroke in the elderly. The Cardiovascular Health Study. , 1998, Stroke.
[6] FRCP W. J. MacLennan MD,et al. The Elderly , 1984, Treatment in Clinical Medicine.
[7] H. Freund,et al. Cerebral microembolism in symptomatic and asymptomatic high‐grade internal carotid artery stenosis , 1994, Neurology.
[8] Maarten Schrooten,et al. Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale , 2009, Stroke.
[9] P A Schneider,et al. Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. , 1988, Stroke.
[10] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.
[11] S. Kashyap,et al. Correlation of the Extent and Severity of Atherosclerosis in the Coronary and Cerebral Arteries , 1963, Circulation.
[12] M. Woodward,et al. Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial* , 2011, Stroke.
[13] Eric E. Smith,et al. Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative , 2011, Stroke.
[14] 塩見 紘樹. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention : observational study , 2013 .
[15] G Finet,et al. Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome: A Three-Vessel Intravascular Ultrasound Study , 2002, Circulation.
[16] M. Naghavi,et al. Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice , 2003, Circulation.
[17] Albert van der Zwan,et al. Anatomy and Functionality of Leptomeningeal Anastomoses: A Review , 2003, Stroke.
[18] V. Fuster,et al. Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study , 2009, Circulation. Cardiovascular imaging.
[19] C. Seiler,et al. The human coronary collateral circulation , 2003, Heart.
[20] V. Fuster,et al. Coronary plaque disruption. , 1995, Circulation.
[21] S. Nissen. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. , 2005, The American journal of cardiology.
[22] R. Virmani,et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.
[23] R B D'Agostino,et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. , 2000, American heart journal.
[24] A. Norbash,et al. Cerebral Collateral Circulation in Carotid Artery Disease , 2009, Current cardiology reviews.
[25] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[26] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[27] W. Schaper,et al. Collateral Circulation , 1993, Springer US.
[28] Rowena J Dolor,et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.
[29] Louis E. Teichholz,et al. Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .
[30] D. Liebeskind. Collateral circulation. , 2003, Stroke.
[31] J. Danesh,et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.
[32] J. Alpert,et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. , 2003, Stroke.
[33] V. Aboyans,et al. Indications for carotid screening in patients with coronary artery disease. , 2009, Presse medicale.
[34] L. Solberg,et al. Distribution of cerebral atherosclerosis by geographic location, race, and sex. , 1968, Laboratory investigation; a journal of technical methods and pathology.
[35] Y. Kihara,et al. Determinants of collateral development in patients with acute myocardial infarction , 1999, Clinical cardiology.
[36] G. Chatellier,et al. Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis , 2005, Stroke.
[37] R. J. Valentine,et al. Trends and outcomes of concurrent carotid revascularization and coronary bypass. , 2008, Journal of vascular surgery.
[38] P. Sandercock,et al. Anticoagulants for Acute Ischemic Stroke , 2004, Advances in neurology.
[39] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[40] P. Shah,et al. Mechanisms of plaque vulnerability and rupture. , 2003, Journal of the American College of Cardiology.
[41] R. Califf,et al. Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience. , 2001, American heart journal.
[42] G. Moneta,et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .
[43] A. Davies,et al. Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.
[44] A. Algra,et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial , 2006, The Lancet.
[45] J. Ornato,et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[46] Wan Ariffin Bin Abdullah. Singapore Med J , 1993 .
[47] P. Rothwell,et al. Risk of Coronary and Other Nonstroke Vascular Death in Relation to the Presence and Extent of Atherosclerotic Disease at the Carotid Bifurcation , 2006, Stroke.
[48] V. Fuster,et al. Thrombosis in unstable angina. , 1992, The New England journal of medicine.
[49] Daniel B Hier,et al. Early Clinical Differentiation of Cerebral Infarction From Severe Atherosclerotic Stenosis and Cardioembolism , 1992, Stroke.
[50] A. Bol,et al. Mechanisms of Chronic Regional Postischemic Dysfunction in Humans New Insights From the Study of Noninfarcted Collateral‐Dependent Myocardium , 1993, Circulation.
[51] D. Weiss,et al. Cardiac Prognosis of Patients With Carotid Stenosis and No History of Coronary Artery Disease , 1994, Stroke.
[52] A. Skene,et al. Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial , 2000, Circulation.
[53] E. Vicaut,et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.
[54] Thomas J. Wang,et al. The search for new cardiovascular biomarkers , 2008, Nature.
[55] J. Cutter,et al. Gender differences in outcome after an acute myocardial infarction in Singapore. , 2002, Singapore medical journal.
[56] Gary Friday,et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American , 2011, Journal of the American College of Cardiology.
[57] M. Kaste,et al. Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis , 2003, Neurology.
[58] Gary Friday,et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline , 2011, Circulation.
[59] J. Alpert,et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. , 2003, Circulation.
[60] X. Álvarez,et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events , 2007 .
[61] Tomohiro Sakamoto,et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. , 2004, Journal of the American College of Cardiology.
[62] R. Collins,et al. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study. , 2011 .
[63] C. Warlow,et al. Evidence of a chronic systemic cause of instability of atherosclerotic plaques , 2000, The Lancet.
[64] Therese Miller,et al. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[65] L. Solberg,et al. SEVERITY OF ATHEROSCLEROSIS IN CEREBRAL ARTERIES, CORONARY ARTERIES, AND AORTAS * , 1968, Annals of the New York Academy of Sciences.
[66] Adrian F Hernandez,et al. Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes , 2011, Circulation.
[67] D. Calvet,et al. Coronary Risk Stratification in Patients with Ischemic Stroke or Transient Ischemic Stroke Attack , 2007, International journal of stroke : official journal of the International Stroke Society.
[68] C F Dewey,et al. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[69] V. Fuster,et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. , 1985, Journal of the American College of Cardiology.
[70] Mary Cushman,et al. Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.
[71] S L Winters,et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. , 1985, Journal of the American College of Cardiology.
[72] Christopher E. Buller,et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.
[73] P. Wolf,et al. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: Insights from the framingham study , 2006, Current atherosclerosis reports.
[74] Peter M. Rothwell,et al. RISK OF STROKE IN THE DISTRIBUTION OF AN ASYMPTOMATIC CAROTID-ARTERY , 1995 .
[75] W. Kannel. Risk Factors for Atherosclerotic Cardiovascular Outcomes in Different Arterial Territories , 1994, Journal of cardiovascular risk.
[76] E. Topol,et al. Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2012, Stroke.
[77] P. Shan,et al. Age‐ and gender‐specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China , 2012, Clinical endocrinology.
[78] P. Rothwell,et al. A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[79] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[80] P. Sandercock,et al. Anticoagulants for acute ischaemic stroke. , 2008, The Cochrane database of systematic reviews.
[81] George Howard,et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes , 2008, The Lancet Neurology.
[82] Heart Protection Study Collaborative Group. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study , 2011, The Lancet.
[83] Deepak L. Bhatt,et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry , 2009, European heart journal.
[84] M. Viergever,et al. Cerebral hemodynamics in relation to patterns of collateral flow. , 1999, Stroke.
[85] Raimund Erbel,et al. [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.
[86] Jinkwon Kim,et al. The Frequency and Risk of Preclinical Coronary Artery Disease Detected Using Multichannel Cardiac Computed Tomography in Patients with Ischemic Stroke , 2012, Cerebrovascular Diseases.
[87] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[88] M. Hennerici,et al. Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2010, Stroke.
[89] Y. Arbel,et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. , 2011, Journal of the American College of Cardiology.
[90] H. Shin,et al. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[91] B. Berk,et al. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[92] A. Grau,et al. Influenza Vaccination Is Associated With a Reduced Risk of Stroke , 2005, Stroke.
[93] A. Grau,et al. Influenza and stroke risk: a key target not to be missed? , 2010, Infectious disorders drug targets.
[94] W S Moore,et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. , 1993, The New England journal of medicine.
[95] G. Simonetti,et al. Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study. , 2009, JACC. Cardiovascular interventions.
[96] K. Furie,et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. , 2008, Stroke.
[97] R. Corston,et al. Prognosis in middle cerebral artery stenosis. , 1984, Stroke.
[98] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[99] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[100] D. Lawlor,et al. Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study , 2000, Journal of epidemiology and community health.